High-energy liquid diet for young children with chronic cholestasis and severe malnutrition
Official title: Preliminary Study: Effect of Nutrition Therapy on Prealbumin and IGF-1 Level in Severe Malnutrition Under Five Years Old With Chronic Cholestasis
Run by Universitas Indonesia · NCT07569003 · Data updated 2026-11-12
This project will see if a 14-day high-energy liquid diet can raise prealbumin and IGF-1 blood levels in children under 5 with chronic cholestasis and severe malnutrition.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 5 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Universitas Indonesia Academic / other |
| Locations | 1 site (Jakarta Pusat, DKI Jakarta) |
| Status | Recruiting |
| Started | April 6, 2026 |
| Main results expected | June 2026 |
| Study ends | July 2026 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT07569003 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 3 to 59 months with diagnosed chronic cholestasis and severe malnutrition whose guardians consent and who can use a nasogastric tube if indicated.
✕Probably not a fit
Children with heart failure, chronic kidney disease, HIV, recent severe acute infections, post-transplant status, or those who are exclusively breastfed are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls malnourished children aged 3 to 59 months with chronic cholestasis to receive a prescribed high-energy liquid diet for 14 days. Blood samples for prealbumin and IGF-1 are taken at baseline and on day 15 to measure biochemical response. Daily food diaries, stool and vomiting records, and monitoring for allergic reactions are collected throughout the intervention, while anthropometric measurements are recorded on days 0, 8, and 15. The protocol excludes children with major comorbidities, recent severe infections, post-transplant status, or exclusive breastfeeding.
Why it matters
Potential benefit: If successful, the diet could improve short-term nutrition markers and help support growth in malnourished children with chronic cholestasis.
How similar studies have gone: Prior nutritional interventions in cholestatic pediatric populations have shown improvements in weight and some biochemical markers, but short-term effects on prealbumin and IGF-1 from a 14-day high-energy liquid diet are not well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children under 5 years old * Diagnosed with chronic cholestasis and severe malnutrition * Parental/guardian informed consent * Willingness to use a nasogastric tube (NGT) if indicated * Covered by national health insurance or other insurance Exclusion Criteria: * Comorbidities (heart failure, chronic kidney disease, HIV) * Severe acute infections (acute gastroenteritis, dengue fever, pneumonia) * Post-liver transplant * Post-Kasai portoenterostomy (jaundice-free) * Currently exclusively breastfeeding * Use of steroids or NSAIDs within two weeks prior to the study. * Receiving a transfusion of whole blood, fresh frozen plasma, or platelets within one week prior to the study
Where it's running
-
Faculty of Medicine, University of Indonesia, Jakarta, DKI Jakarta 10430
Jakarta Pusat, DKI Jakarta, Indonesia Recruiting
Study contacts
- Principal investigator: Tri Faranita, dr, Sp.A — Department of Child Health, Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital
- Study coordinator: Tri Faranita, dr, Sp.A
- Email: tri.faranita@ui.ac.id
- Phone: +628126016641
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Validation of Treatment Decision Algorithms for Childhood Tuberculosis
This study is testing a new way to help doctors in Zambia and Mozambique make better decisions for screening and treating tuberculosis in children under 15 years old.
-
Using azithromycin to treat severe acute malnutrition in children
This study is testing if adding azithromycin to the usual treatment can help young children with severe malnutrition gain weight and improve their health.
-
OptiMAx: testing SQ-LNS to boost vaccination in rural Chad and Niger
This study tests whether giving small-batch SQ-LNS to young children helps increase routine immunizations in rural Chad and Niger.
-
Combining nutrition checks and muscle measurements to predict outcomes after lung cancer surgery
This project will test whether combining nutrition tests and muscle scans can predict recovery, complications, and short-term outcomes in adults having lung cancer surgery.
-
Improving treatment for severe malnutrition in children in Kenya
This study is testing a new way to help young children in Kenya who are severely malnourished by using community health workers with smartphones to improve screening and treatment.
-
Improving treatment for severe acute malnutrition in Ethiopia
This study is testing a new program in Ethiopia that uses community groups to improve how children with severe acute malnutrition get treated and supported.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.